Botulinum Neurotoxins and Advancements in Its Diagnosis

Botulism is a disease caused by botulinum neurotoxins (BoNTs) that lead to flaccid descending paralysis by disrupting nerve cell communication with muscle cells. Antitoxins can slow disease progression, but complications can be fatal if treatment is delayed. Various Clostridium species produce highly lethal BoNTs that target different substrates, affecting humans and animals differently. The protein structure of BoNTs involves a heavy chain aiding in receptor binding and a light chain that cleaves SNARE proteins. In animals, botulism symptoms include paralysis, vision disturbances, and difficulty swallowing, leading to death from respiratory or cardiac paralysis. Diagnostic methods include mouse bioassays, cell-based assays, endopeptidase mass spectrometry assays, immunoassays, nucleic acid testing, and comparative genomic methods. Biosensors and electrochemical methods have also been developed for detection. Prompt diagnosis is crucial for treatment with antitoxins, and specialized reagents are needed for accurate testing, taking into consideration testing turnaround time for effective public health response.